Reagents, cell lines
Wortmannin was purchased from Sigma. The GSC5 cell line was derived from SV40-transformed GM639 human fibroblasts and contains the GFP-based and CD4-based sustrates (15, 38, 39) . GSC5 were cultured in Dulbecco's modified Eagle's medium-1g/L D-glucose containing 10% fetal calf serum, 1% Gentamicin and supplemented with 3µg/mL blasticidin and 350 µg/mL neomycin to maintain the expression of CD4 and GFP respectively.
Quantitative RT-PCR
Total RNA was extracted from siRNA-transfected control and PARP3 kd -cells using the RNAeasy kit (Qiagen) according to the manufacturer's protocol. DNase-treated RNA was processed for reverse transcription using the Maxima Reverse Transcriptase (Thermo Scientific) according to the manufacturer's instructions. Real time PCR was performed using the QuantiTect SYBR Green PCR kit following the manufacturer's instructions (Qiagen) combined with the Applied Biosystems StepOne (Life technologies) detection system. The PCR products were analysed with the StepOne Software. The quantity of PCR products was estimated by the relative standard curve method. All samples were analyzed in triplicates and normalized using the gapdh housekeeping gene. The following primer sequences were used : Parp3, Fwd, TGGCAAGGGCATCTACTTTG ; Rev, TCCGTGTTGATATGGTGCTC ; Mre11, Fwd, ATCTCACAACCTGGAAGCTCAG, Rev, TGAAAAACTGCCGCACTGTG ; CtIP, Fwd, TGACCTGTCCAAAGACGACTTG, Rev, AGCTGCTTCCCGAGATGTTC ; Exo1, Fwd, ACTTCTTCGTGAGGGGAAAGTC, Rev, ATTACTTTGTGGGCCATGGC ; Gapdh: Fwd, ATGTTCGTCATGGGTGTGAA, Rev, GTCTTCTGGGTGGCAGTGAT. Ligase III, Fwd, GATCACGTGCCACCTACCTTGT, Rev, GGCATAGTCCACACAGAACCGT.
Mouse embryonic fibroblasts and cell viability. The wild-type (Parp3 +/+ ) and Parp3 null (Parp3 -/-) mouse embryonic fibroblasts (MEFs) were generated as previously described (98). The mice have been described (33). Cells were maintained in Dulbecco's modified Eagle's medium-4,5g/L D-glucose supplemented with 10% fetal calf serum and 1% Gentamicin at 37°C in 5% CO 2 . For cell viability, cells were seeded onto 6-well plates at 75000 cells/well. The next day, cells were mock-treated or exposed to etoposide at 0,5 µM for 4h. Three days later, cells were diluted at ¼ to prevent confluency. Viability was analysed 6 days later using the blue trypan exclusion test. 
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